Literature DB >> 19324488

[Lung cancer in Spain. Current epidemiology, survival, and treatment].

Julio Sánchez De Cos Escuín1.   

Abstract

In 2005, 19 115 people died of lung cancer in Spain. In spite of the increase since 1950 in absolute mortality rates, the adjusted rate for men has declined. The incidence among women is lower in Spain than in other countries but it has increased (with a ratio of 1 woman for every 8.5 men). More than 50% of the patients are over 70 years of age. While the proportion of adenocarcinomas relative to other histological types has increased worldwide, squamous cell carcinoma still predominates in Spain (ranging from 24%-50.5%). The number of patients treated by surgical resection has not increased (14.8% in Spain in 2003). Operative mortality is 6.8%. Between 25% and 50% of patients receive only palliative medication. Absolute overall survival in patients with lung cancer is under 10% in many countries. The 5-year survival rate among patients treated surgically has increased slightly, with stage IA rates ranging from 58.3% to 68.5% and stage IIIA from 28.3% to 35.8%.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19324488     DOI: 10.1016/j.arbres.2008.06.005

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  5 in total

1.  Outcome and toxicity of intensity modulated radiotherapy with simultaneous integrated boost in locally advanced non-small cell lung cancer patients.

Authors:  A Fondevilla Soler; J L López-Guerra; M Dzugashvili; P Sempere Rincón; A Sautbaet; P Castañeda; J M Díaz; J M Praena-Fernandez; E Rivin Del Campo; I Azinovic
Journal:  Clin Transl Oncol       Date:  2017-06-06       Impact factor: 3.405

2.  Ectoenzymes and cholinesterase activity and biomarkers of oxidative stress in patients with lung cancer.

Authors:  Daniela Zanini; Roberta Schmatz; Luana Paula Pelinson; Victor Camera Pimentel; Pauline da Costa; Andréia Machado Cardoso; Caroline Curry Martins; Christina Chitolina Schetinger; Jucimara Baldissareli; Maria do Carmo Araújo; Liliane Oliveira; Juarez Chiesa; Vera Maria Morsch; Daniela Bitencourt Rosa Leal; Maria Rosa Chitolina Schetinger
Journal:  Mol Cell Biochem       Date:  2012-11-18       Impact factor: 3.396

3.  Prevalence of benign pulmonary lesions excised for suspicion of malignancy: could it reflect a quality management index of indeterminate lung lesions?

Authors:  Gerardo Andrés Obeso Carillo; José Eduardo Rivo Vázquez; Alberto Fernández Villar
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2014-10-05

4.  SIRT3 acts as a novel biomarker for the diagnosis of lung cancer: A retrospective study.

Authors:  Feng Tao; Chao Gu; Na Li; Ying Ying; Yongzhi Feng; Dan Ni; Qi Zhang; Qinfeng Xiao
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

5.  Pattern of use of radiotherapy for lung cancer: a descriptive study.

Authors:  Isabel Tovar; Jose Expósito; Javier Jaén; Enrique Alonso; Miguel Martínez; Rosa Guerrero; Juan P Arrebola; Rosario Del Moral
Journal:  BMC Cancer       Date:  2014-09-23       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.